{"blog": [], "keywords": [{"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "1", "is_major": "N"}, {"value": "Mylan Inc", "name": "organizations", "rank": "2", "is_major": "N"}, {"value": "Perrigo Company", "name": "organizations", "rank": "3", "is_major": "N"}, {"value": "Teva Pharmaceutical Industries Ltd", "name": "organizations", "rank": "4", "is_major": "N"}, {"value": "Bresch, Heather", "name": "persons", "rank": "5", "is_major": "N"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "6", "is_major": "N"}], "web_url": "http://www.nytimes.com/2015/05/09/business/dealbook/mylans-too-harsh-takeover-defense.html", "document_type": "article", "byline": {"person": [{"middlename": "Davidoff", "firstname": "Steven", "role": "reported", "rank": 1, "lastname": "SOLOMON", "organization": ""}], "original": "By STEVEN DAVIDOFF SOLOMON"}, "type_of_material": "News", "multimedia": [], "section_name": "Business Day", "word_count": "1429", "source": "The New York Times", "subsection_name": "DealBook", "lead_paragraph": "In trying to fend off Teva, the drug maker is sending a message that may set off a shareholder revolt.", "pub_date": "2015-05-09T00:00:00Z", "news_desk": "Business", "headline": {"kicker": "Deal Professor", "main": "Mylan\u2019s Too-Harsh Takeover Defense", "content_kicker": "Deal Professor"}, "print_page": null, "snippet": "In trying to fend off Teva, the drug maker is sending a message that may set off a shareholder revolt.", "_id": "554d0e3c38f0d8188877cc0a", "slideshow_credits": null, "abstract": null}